Loading chart…
PRE-MARKET
Akums Drugs and Pharmaceuticals Limited manufactures and sells pharmaceutical products and active pharmaceutical ingredients India and internationally. The company provides drugs, ayurvedic, nutraceuticals, food and dietary supplements, derma and cosmetics, healthcare and hospital products, over-the-counter (OTC) products, active pharmaceutical ingredients, excipients, and compounds.
Akums Drugs and Pharmaceuticals Limited (AKUMS) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The AKUMS share price is ₹765.85 (+4.20% today), with a market capitalisation of ₹117B and a price-to-earnings (P/E) ratio of 32.2. MarketRipple tracks the AKUMS investment thesis, the ripple-chain impact of market events on Akums Drugs and Pharmaceuticals Limited, and the Healthcare sector outlook.
Open
₹740.10
High
₹784.90
Low
₹740.10
Prev. Close
₹734.95
52W High
₹838.80
52W Low
₹409.30
Day range
₹740.10–₹784.90
52-week range
₹409.30–₹838.80
Volume
655K
P/E
32.2
ROE
10.9%
D/E
0.06
Margin
7.5%
Akums Drugs and Pharmaceuticals Limited (NSE: AKUMS) is currently trading at ₹765.85 (+4.20%).
Akums Drugs and Pharmaceuticals Limited's market capitalization is ₹117B.
Akums Drugs and Pharmaceuticals Limited's price-to-earnings (P/E) ratio is 32.2.
Akums Drugs and Pharmaceuticals Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).
Analyst consensus on Akums Drugs and Pharmaceuticals Limited currently reads strongly positive, based on 3 analysts covering the stock. This is third-party analyst data, not a MarketRipple recommendation.